# Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients

> **NCT04130685** · — · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 48 (actual)

## Conditions studied

- Pancreas Transplant Rejection
- Kidney Transplant Rejection

## Interventions

- **DIAGNOSTIC_TEST:** Allosure Test

## Key facts

- **NCT ID:** NCT04130685
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-15
- **Primary completion:** 2021-05-31
- **Final completion:** 2022-12-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130685, "Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04130685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*